Trial · NCT03138512
Results by group274
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 274
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disease-Free Survival (DFS) by BICR - Treatment Part A and B | Treatment Part A: Nivo + Ipi | NA | 95% Confidence Interval NA to NA | Months | |
| Disease-Free Survival (DFS) by BICR - Treatment Part A and B | Treatment Part A: Placebo | NA | 95% Confidence Interval 65.58 to NA | Months | |
| Disease-Free Survival (DFS) by BICR - Treatment Part A and B | Treatment Part B: Placebo | NA | 95% Confidence Interval NA to NA | Months | |
| Disease-Free Survival (DFS) by BICR - Treatment Part A and B | Treatment Part B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - Treatment Part A and B | Treatment Part A: Nivo + Ipi | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - Treatment Part A and B | Treatment Part A: Placebo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - Treatment Part A and B | Treatment Part B: Placebo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - Treatment Part A and B | Treatment Part B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) Rate (5 Years) - Treatment Part A and B | Treatment Part A: Nivo + Ipi | 85.0 | 95% Confidence Interval 80.8 to 88.3 | Percent of participants | |
| Overall Survival (OS) Rate (5 Years) - Treatment Part A and B | Treatment Part A: Placebo | 87.2 | 95% Confidence Interval 82.8 to 90.5 | Percent of participants | |
| Disease-Free Survival (DFS) Per BICR in Contemporaneously Randomized Combination and Monotherapy Participants - Treatment Part B | Treatment Part B: Nivo + Ipi | NA | 95% Confidence Interval 36.17 to NA | Months | |
| Disease-Free Survival (DFS) Per BICR in Contemporaneously Randomized Combination and Monotherapy Participants - Treatment Part B | Treatment Part B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) in the Contemporaneously Randomized Combination and Monotherapy Participants - Treatment Part B | Treatment Part B: Nivo + Ipi | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) in the Contemporaneously Randomized Combination and Monotherapy Participants - Treatment Part B | Treatment Part B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Nivo + Ipi | Any Grade AE | 392 | Participants | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Placebo | Any Grade AE | 362 | Participants | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Nivo + Ipi | Grade 3-4 AE | 154 | Participants | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Placebo | Grade 3-4 AE | 44 | Participants | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Nivo + Ipi | Grade 5 AE | 1 | Participants | |
| The Number of Participants With Adverse Events up to 30 Days After Last Dose of Study Therapy - Treatment Part A | Treatment Part A: Placebo | Grade 5 AE | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03138512/results